ANITA CLAYTON: Open Payments
NPI 1104951391 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$62,448 in 84 payments from 7 companies in 2025. Trend: 2023 $52,334 · 2024 $25,947 · 2025 $62,448
Consulting: $53,185Travel & lodging: $6,046Food & beverage: $2,082Education: $1,135
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $23,510 |
| Axsome Therapeutics, Inc. | 2 | $23,188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $10,891 |
| Neurocrine BioSciences, Inc. | 15 | $2,424 |
| Neos Therapeutics, LP | 1 | $1,725 |
| Janssen Scientific Affairs, LLC | 11 | $657 |
| Sage Therapeutics, LLC | 1 | $52 |
Products named: Auvelity, CAPLYTA, BOTOX, EXXUA, VRAYLAR, SPRAVATO, ZURZUVAE.
Industry payments across VA — which companies pay providers there.
